BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250925T170000
DTEND;TZID=Europe/London:20250925T180000
DTSTAMP:20260828T090533
CREATED:20250520T203901Z
LAST-MODIFIED:20250919T113423Z
UID:100112612-1758819600-1758823200@www.pathologynews.com
SUMMARY:Prognostic Risk Profiling from Digitized H&E: a look at new international performances of an AI model for breast cancer
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link\, available below! \nJoin expert pathologist\, Magali Lacroix-Triki\, and Owkin senior data scientist\, Valentin Guary\, as they present new findings on RlapsRisk® BC\, an innovative AI-driven solution for breast cancer recurrence risk assessment from digital pathology slides. This webinar will showcase comprehensive data comparing RlapsRisk® BC’s performance against traditional clinical scores and established molecular tests. Our panel will discuss how this revolutionary tool helps to enhance prognostic accuracy and has the potential to transform treatment decision-making in breast cancer care. \nAttendees will gain valuable insights into:\n▪ The impact of AI-powered digital pathology solutions for outcome and prognostic prediction\n▪ Latest performance results from ongoing studies\n▪ First comparisons with current testing approaches\n▪ Real-world implementation experiences\n▪ Potential impact on treatment planning and patient care \nRlapsRisk® BC is under development and not for clinical use. It is not FDA cleared or approved in the USA. RlapsRisk® BC is developed within the PortrAIt consortium\, a french consortium financed by the government within the framework of France 2030 and by the European Union – Next Generation EU within the framework of the France Relance Plan. \nRegister Here
URL:https://www.pathologynews.com/event/prognostic-risk-profiling-from-digitized-he-a-look-at-new-international-performances-of-an-ai-model-for-breast-cancer/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/gif:https://www.pathologynews.com/wp-content/uploads/2025/05/Featured-Image-Breast-Cancer-Recurrence-Risk-Assessment-from-Digitized-HE-with-RlapsRisk-BC-a-Clinically-Validated-AI-Prognostic-Solution.gif
END:VEVENT
END:VCALENDAR